RedHill Biopharma (RDHL) EBITDA Margin Growth (3y) (2015 - 2023)
Powered by 
Analysis
RedHill Biopharma (RDHL) EBITDA Margin Growth (3y) (2015 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 1,129.00 |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -925.00 |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -2,128.00 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 293.00 |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 693.00 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -230,408.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 457.00 |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | -372.00 |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 15,005.00 |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 293,306.00 |
| Mar 31, 2023 | -241,937.00 |
| Dec 31, 2022 | -133,169.00 |
| Sep 30, 2022 | -66,214.00 |
| Jun 30, 2022 | -74,214.00 |
| Mar 31, 2022 | -40,350.00 |
| Dec 31, 2021 | -138,043.00 |
| Sep 30, 2021 | -36,083.00 |
| Jun 30, 2021 | -29,094.00 |
| Mar 31, 2021 | -32,057.00 |
| Dec 31, 2020 | -62,611.00 |
| Sep 30, 2020 | -84,790.00 |
| Jun 30, 2020 | -274,329.00 |
| Jun 30, 2019 | -71.86 Mn |
| Jun 30, 2018 | -58.86 Mn |
| Mar 31, 2018 | -47.51 Mn |
| Dec 31, 2017 | -48.07 Mn |
| Sep 30, 2017 | -12.44 Mn |
| Jun 30, 2017 | -10.00 Mn |
| Jun 30, 2016 | 78.26 Mn |